SamaCare

🔍 Premium Feature Series: We’re spotlighting a SamaCare product that’s transforming the Script-to-Therapy™ journey. SamaCare is more than just a tool; it’s a community dedicated to enhancing patient access. See how our solutions make a meaningful difference, always available to providers at no cost. This Week: BV Ease™ Accelerate your specialty drug's prior authorization (PA) with BV Ease. Effortlessly verify benefits and assess PA needs—all within the SamaCare platform. Fast, efficient, and fully integrated. Stay tuned for more feature highlights, and discover how SamaCare’s premium tools can elevate your specialty product's market presence. Explore more on our site: https://lnkd.in/eUpE3RfJ

Launching a new provider-administered drug in today’s competitive market involves more than just clinical efficacy. Non-clinical factors like financial risk and administrative challenges play a pivotal role in HCOs' adoption decisions. To successfully introduce new treatments, pharmaceutical companies must strategically address these concerns and collaborate closely with providers. Want to learn more about how SamaCare can help bridge the gap? Click here to explore how partnering with us can enhance your drug launch strategy: https://lnkd.in/eUpE3RfJ Also, check out our latest article for key strategies below: #Pharma #HealthcareInnovation #SpecialtyDrugLaunches

We'll be at the Healthcare Advocate Summit next week to discuss #patientaccess #priorauthorization #reimbursement and more. Visit SamaCare at booth 318 to learn how our cloud-based patient access platform helps specialty providers simplify the journey from diagnosis to treatment. #ForAdvocates #marketaccess #patientcare

How can practices tackle the rising resource cost of prior authorizations? Listen to our full podcast with the American Society of Ophthalmic Administrators (ASOA) to find out: https://lnkd.in/eDAjEkdF #priorauthorization #retina #ASOA #podcast #EyeTalksRadio #revenuecyclemanagement

🚀 New Article Alert! 🚀 The script-to-therapy journey for specialty meds is full of challenges. In this new Pharmaceutical Executive article, our CEO, Syam Palakurthy, shares key strategies to drive enhanced access and better outcomes. At SamaCare, our mission is to simplify the prior authorization process so patients can start therapy sooner. We're proud to be featured and highlight how the landscape is evolving to overcome these barriers. Big thanks to Pharmaceutical Executive for the feature! Read the full article here: https://lnkd.in/ed-xQmSN #PharmaInnovation #PatientAccess #PriorAuthorization #SpecialtyDrugs #ScriptoTherapy

A big thank you to the American Society of Ophthalmic Administrators (ASOA) for having Kip Theno on EyeTalks Radio, and to Erin Bishop of EyeCare Partners for joining us. Tune in to hear their insights into the challenges #retina practices are facing when it comes to prior authorizations, reimbursement, and managing the growing workload while still delivering great care. This is a podcast you won't want to miss! ✅ https://lnkd.in/eqEnDdpa

Over 40% Increase in Prior Authorization Approvals? Yes, It’s Possible! In the competitive landscape of specialty pharma, staying ahead isn’t just about launching innovative treatments—it’s also about ensuring that patients have seamless access. At SamaCare, we’re helping pharma companies do just that, driving operational efficiency and improving patient access across the board. Take neurotoxin therapies as an example—when navigating complex prior authorizations, the stakes are high. Our cutting-edge platform simplifies the PA process, leading to faster approvals and helping your products reach the patients who need them most. We’ve just launched our new website! Visit us to learn more about how we’re transforming patient access and helping your products stand out in the market: https://lnkd.in/eUpE3RfJ #PriorAuthorization #PatientAccess #NeurotoxinTherapy #SpecialtyPharma #HealthcareInnovation

In crowded specialty markets, such as neurotoxin therapies, navigating prior authorizations (PA) is a critical factor for successful market entry and patient access. At SamaCare, we empower pharmaceutical leaders with advanced strategies to streamline the PA process, minimize barriers, and accelerate access to therapy. Here are five key challenges you may encounter—and how SamaCare can help you overcome them. https://lnkd.in/eUpE3RfJ #Pharma #PriorAuthorization #HealthcareInnovation #SamaCare #PatientAccess #NeurotoxinTherapy

We're thrilled to share that SamaCare has made the Inc. 5000 2024 list of America’s fastest-growing private companies! 🚀 We’ve not only ranked in the top 25% overall but also achieved the #94 spot in Health Services. This milestone is a testament to our mission of revolutionizing prior authorizations, helping healthcare providers get life-changing treatments to patients faster. We couldn’t have done it without our dedicated team and incredible partners. Here’s to pushing boundaries, driving innovation, and continuing our growth journey together! See our full profile here: https://lnkd.in/eGba6bYz #Inc5000 #HealthcareExcellence #InnovationInAction #SamaCareSuccess

Welcome to our new practices who have embarked on the first step to improving the prior authorization process this summer! ☀ 👋